Fluid biomarkers in cerebral amyloid angiopathy
Cerebral amyloid angiopathy (CAA) is a type of cerebrovascular disorder characterised by
the accumulation of amyloid within the leptomeninges and small/medium-sized cerebral …
the accumulation of amyloid within the leptomeninges and small/medium-sized cerebral …
Cerebrospinal fluid shotgun proteomics identifies distinct proteomic patterns in cerebral amyloid angiopathy rodent models and human patients
M Vervuurt, JM Schrader, AM de Kort, I Kersten… - Acta Neuropathologica …, 2024 - Springer
Cerebral amyloid angiopathy (CAA) is a form of small vessel disease characterised by the
progressive deposition of amyloid β protein in the cerebral vasculature, inducing symptoms …
progressive deposition of amyloid β protein in the cerebral vasculature, inducing symptoms …
CSF and plasma biomarkers in cerebral amyloid angiopathy: A single-center study and a systematic review/meta-analysis
A Theodorou, I Tsantzali, MI Stefanou… - European Stroke …, 2024 - journals.sagepub.com
Introduction: There are limited data regarding cerebrospinal fluid (CSF) and plasma
biomarkers among patients with Cerebral Amyloid Angiopathy (CAA). We sought to …
biomarkers among patients with Cerebral Amyloid Angiopathy (CAA). We sought to …
Proximity extension assay in cerebrospinal fluid identifies neurofilament light chain as biomarker of neurodegeneration in sporadic cerebral amyloid angiopathy
M Vervuurt, HB Kuiperij, AM de Kort, I Kersten… - Alzheimer's Research & …, 2024 - Springer
Background Sporadic cerebral amyloid angiopathy (sCAA) is a disease characterised by the
progressive deposition of the amyloid beta (Aβ) in the cerebral vasculature, capable of …
progressive deposition of the amyloid beta (Aβ) in the cerebral vasculature, capable of …
Non‐hemorrhagic imaging markers of cerebral amyloid angiopathy in memory clinic patients
AS Costa, M Albrecht, A Reich… - Alzheimer's & …, 2024 - Wiley Online Library
INTRODUCTION The Boston criteria v2. 0 for cerebral amyloid angiopathy (CAA)
incorporated non‐hemorrhagic imaging markers. Their prevalence and significance in …
incorporated non‐hemorrhagic imaging markers. Their prevalence and significance in …
[PDF][PDF] Fluid biomarkers in cerebral
Proteins that are considered amyloidogenic can undergo conformational changes, leading
to the formation of β-sheet aggregates. The aggregated amyloidogenic proteins make …
to the formation of β-sheet aggregates. The aggregated amyloidogenic proteins make …
[PDF][PDF] Proximity extension assay biomarker discovery in cerebrospinal fluid reveals NFL as biomarker of neurodegeneration in cerebral amyloid angiopathy
M Vervuurt - PROTEOMIC SECRETS OF THE …, 2024 - repository.ubn.ru.nl
Background Sporadic cerebral amyloid angiopathy (sCAA) is a neurovascular disease
characterised by the accumulation of amyloid-beta protein in cerebral blood vessels …
characterised by the accumulation of amyloid-beta protein in cerebral blood vessels …
[PDF][PDF] Non‐hemorrhagic imaging markers of cerebral amyloid angiopathy in memory clinic patients
AS Ferreira Braga da Costa - d-nb.info
INTRODUCTION: The Boston criteria v2. 0 for cerebral amyloid angiopathy (CAA)
incorporated non-hemorrhagic imaging markers. Their prevalence and significance in …
incorporated non-hemorrhagic imaging markers. Their prevalence and significance in …